Quest Diagnostics Incorporated (DGX) vs IDEXX Laboratories, Inc. (IDXX)

Quest Diagnostics Incorporated and IDEXX Laboratories, Inc. are both Diagnostics & Research companies. IDEXX Laboratories, Inc. is the larger, with a market value of $52.8B against $28.0B — 1.9× the size. Quest Diagnostics Incorporated trades at the lower P/E: 25.0× against 44.8×. IDEXX Laboratories, Inc. grew revenue faster over the last twelve months: 11.9% against 9.13%. IDEXX Laboratories, Inc. has the higher net margin (25.4% vs 9.50%) and the higher return on invested capital (46.0% vs 8.48%). Across the 22 metrics below, IDEXX Laboratories, Inc. leads on 13 and Quest Diagnostics Incorporated on 9.

Valuation

Metric DGX IDXX Diagnostics & Research median
P/E 24.98 44.83 34.52
P/S 2.36 11.31 4.24
P/B 3.52 28.21 3.42
Price to free cash flow 20.34 40.57 33.51
EV/EBITDA 14.18 31.80 23.44
EV/Sales 2.76 11.35 5.18
Earnings yield 4.00% 2.23% (1.50%)
Free cash flow yield 4.92% 2.47% 0.00%

Profitability

Metric DGX IDXX Diagnostics & Research median
Gross margin 33.11% 62.72% 48.32%
Operating margin 14.55% 32.30% (5.68%)
Net margin 9.50% 25.36% (4.10%)
Free cash flow margin 11.61% 27.88% 0.00%
Return on equity 14.76% 68.93% 0.00%
Return on assets 6.73% 33.33% (6.05%)
Return on invested capital 8.48% 46.00% 0.00%

Growth

Metric DGX IDXX Diagnostics & Research median
Revenue growth (TTM) 9.13% 11.87% 8.99%
EPS growth (last fiscal year) 13.78% 22.59% 20.36%
Revenue growth, 5-year CAGR 3.18% 9.72% 7.30%
Net income growth, 5-year CAGR (7.06%) 12.74% 0.00%

Health

Metric DGX IDXX Diagnostics & Research median
Debt to equity 0.70 0.20 0.01
Current ratio 1.70 1.19 2.27
Net debt to EBITDA 2.47 0.18 0.68

Dividend

Metric DGX IDXX Diagnostics & Research median
Dividend yield 1.33% — 0.67%
Payout ratio 0.34 — 0.20

Size

Metric DGX IDXX Diagnostics & Research median
Market cap 28.03b 52.84b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack